Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults

BACKGROUND AND OBJECTIVES: Dasotraline is a novel inhibitor of dopamine and norepinephrine reuptake currently being investigated in clinical studies for the treatment of attention-deficit/hyperactivity disorder (ADHD). Uniquely, relative to current ADHD medications, dasotraline has a slow absorption...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Seth C., Sunkaraneni, Soujanya, Skende, Estela, Hing, Jeremy, Passarell, Julie A., Loebel, Antony, Koblan, Kenneth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740560/
https://www.ncbi.nlm.nih.gov/pubmed/26597180
http://dx.doi.org/10.1007/s40261-015-0358-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740560/
https://www.ncbi.nlm.nih.gov/pubmed/26597180
http://dx.doi.org/10.1007/s40261-015-0358-7

Ejemplares similares